[1]宋 燕,邵冬华,何美琳,等.PNPLA3基因多态性与非酒精性脂肪性肝病关系的初步探讨[J].现代检验医学杂志,2016,31(04):5-9.[doi:10.3969/j.issn.16717-414.2016.04.002]
　SONG Yan,SHAO Dong-hua,HE Mei-lin,et al.Preliminary Discussion of the Relationship between PNPLA3 Polymorphism and NAFLD[J].Journal of Modern Laboratory Medicine,2016,31(04):5-9.[doi:10.3969/j.issn.16717-414.2016.04.002]
点击复制

PNPLA3基因多态性与非酒精性脂肪性肝病关系的初步探讨()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年04期
页码:
5-9
栏目:
论著
出版日期:
2016-08-10

文章信息/Info

Title:
Preliminary Discussion of the Relationship between PNPLA3 Polymorphism and NAFLD
文章编号:
1671-7414(2016)04-005-05
作者:
宋 燕; 邵冬华; 何美琳; 梁国威
航天中心医院,北京 100049
Author(s):
SONG Yan; SHAO Dong-hua; HE Mei-lin; LIANG Guo-wei
Aerospace Center Hospital,Beijing 100049,China
关键词:
PNPLA3;  多态性;  非酒精性脂肪性肝病;  Logistic回归
分类号:
R575; Q786
DOI:
10.3969/j.issn.16717-414.2016.04.002
文献标志码:
A
摘要:
目的 分析PNPLA3基因多态性与非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)的关系,探讨PNPLA3 rs738409G突变基因携带者NAFLD发生的危险因素,为预防NAFLD的发生提供理论依据。方法 收集航天中心医院2012年～2013年体检者共617例,包括324例健康者和293例NAFLD患者。采用实时荧光定量PCR法检测所有研究对象的rs738409分型,并采用Oneway ANOVA比较不同基因型组之间年龄,性别,BMI,TG,CHOL,hs-CRP,ALT,AST,FPG,HbA1c,CEA,AFP和CA19-9差异有无统计学意义。采用单因素方差分析比较健康组和NAFLD组之间部分生化检测指标和肿瘤标志物的表达水平差异有无统计学意义。Logistic回归分析用于评估rs738409G携带者NAFLD发生的危险因素。结果 ALT(U/L)在CC,CG和GG基因型中的血清水平分别是17.8(12.9,25.3),20.00(14.40,27.65)和20.2(14.85,38.8),表达水平逐渐增高,差异均具有统计学意义(P值均<0.05)。AST(U/L)在CC,CG和GG基因型中的血清水平分别是20.3(17.6,24.5),20.70(17.95,25.20)和22.3(18.60,29.65),仅在CC组和GG组(P=0.000)、CG和GG组(P=0.004)之间的差异具有统计学意义(P值均<0.05)。年龄,性别,BMI,TG,CHOL,hs-CRP,FPG,HbA1c,CEA,AFP和CA19-9在不同基因型的表达差异无统计学意义(P值均>0.05)。BMI(Kg/m2),ALT(U/L),AST(U/L),TG(mmol/L),hs-CRP(mg/ml),FPG(mmol/L)和HbA1c(%)在NAFLD患者组与健康对照组中的表达水平分别是[22.97±2.58 vs 26.74±2.35],[15.65(11.97,21.3)vs 24(17.55,35.4)],[19.8(17.3,23.5)vs 22(18.9,,27.35)],[0.99(0.75,1.40)vs 1.77(1.23,2.54)],[0.89(0.64,1.41)vs 1.43(0.96,2.51)],[4.88(4.61,5.21)vs 5.14(4.82,5.62)]和[5.50(5.3,5.7)vs 5.70(5.45,6.00)],差异均具有统计学意义(P值均<0.05)。Logistic回归分析结论显示,BMI,TG,ALT和HbA1c是rs738409G突变基因携带者NAFLD的危险因素,回归系数分别是0.707,2.968,2.765和21.301。结论 对于rs738409G突变基因健康携带者应该定期监测BMI,TG,ALT和HbA1c,预防NAFLD的发生。
Abstract:
Objective To analyze the relationship between PNPLA3 polymorphism and NAFLD,detect the risk factors of NAFLD for healthy subjects with G allele at rs738409,and provide the theory basis for prevention of NAFLD.Methods 617 health examination subjects from 2012～2013 in Aerospace Center Hospital were enrolled in this study and divided into 2groups,324 healthy ones and 293 NAFLD patients.Real-time fluorescence quantitative PCR(RT-PCR)was used to detect genotype,while age,BMI,TG,CHOL,hs-CRP,ALT,AST,FPG,HbA1c,CEA,AFP and CA19-9 were analyzed among different genotype groups.One way ANOVA was applied to analyze BMI,TG,CHOL,hs-CRP,ALT,AST,FPG,HbA1c,CEA,AFP and CA19-9 between healthy subjects and NAFLD patients.Logistic regression was used to find out the NAFLD risk factors in healthyperson with G allele at rs738409.Results Serum ALT(U/L)levels in CC/CG/GG genotype groups were 17.8(12.9, 25.3),20.00(14.40,27.65)and 20.2(14.85,38.8),respectively,P<0.05.AST(U/L)levels in CC/CG/GG genotype groups were 20.3(17.6,24.5),20.70(17.95,25.20)and 22.3(18.60,29.65),but only difference in CC/GG and CG/GG was significant,andP value were 0.000 and 0.004 respectively.Differences of age,BMI,TG,CHOL,hs-CRP,FPG,HbA1c,CEA,AFP and CA19-9 among CC/CG/GG genotype groups were not significant,and all P values>0.05.BMI(Kg/m2),ALT(U/L),AST(U/L),TG(mmol/L),hs-CRP(mg/ml),FPG(mmol/L)and HbA1c(%)levels between healthy subjects and NAFLD patients were [22.97±2.58 vs 26.74±2.35],[15.65(11.97,21.3)vs 24(17.55,35.4)],[19.8(17.3,23.5)vs 22(18.9,27.35)],[0.99(0.75,1.40)vs 1.77(1.23,2.54)],[0.89(0.64,1.41)vs 1.43(0.96,2.51)],[4.88(4.61,5.21)vs 5.14(4.82,5.62)],[5.50(5.3,5.7)vs 5.70(5.45,6.00)], respectively,P<0.05,and the difference was statistically significant.BMI,ALT,TG and HbA1c were risk factorsof NAFLD for healthy person with G allele at rs738409 by logistic regression,and the regression coefficients were 0.707,2.968,2.765 and 21.301.Conclusion It is necessary for healthy person with G allele at rs738409 to monitor BMI,ALT,TG and HbA1c,which will reduce the incidence of NAFLD in the future.

参考文献/References:

[1] Li Q,Qu HQ,Rentfro AR,et al.PNPLA3 polymorphismsand liver aminotransferase levels in a mexican american population[J].Clin Invest Med,2012,35(4):E237-245.
[2] Pan Q,Zhang RN,Wang YQ,et al.Linked PNPLA3 polymorphisms confer susceptibility tononalcoholic steatohepatitis and decreased viral load inchronic hepatitis B[J].World Journal of Gastroenterology,2015,21(28):8605-8614.
[3] He S,McPhaul CJ,Li JZ,et al.A sequence variation(I148M)in PNPLA3 associated with nonalcoholic fFatty liver disease disrupts triglyceride hydrolysis[J].J Biol Chem,2010,285(9):6706-6715.
[4] Zhang Y,Cai W,Song J,et al.Association between the PNPLA3 I148M polymorphism and non-alcoholic fatty liver disease in the uygur and han ethnic groupsof northwestern China[J].PLoS One,2014,9(10):e108381.
[5] Ratziu V,Bellentani S,Cortez-Pinto H,et al.A position statement on NAFLD/NASH based on the EASL 2009 special conference[J].J Hepatol,2010,53(2):372-384.
[6] Bhala N,Jouness RI,Bugianesi E.Epidemiology and natural history of patients with NAFLD[J].Curr Pharm Des,2013,19(29):5169-5176.
[7] Agrawal A,Duseja AK.Non-alcoholic fatty liver disease:east versus west[J].J Clin Exp Hepatol,2012,2(2):122-134.
[8] Xu R,Tao A,Zhang S,et al.Association between patatin-like phospholipase domain containing 3 gene(PNPLA3)polymorphisms and nonalcoholic fatty liverdisease:A HuGE review and meta-analysis[J].Scientific Reports,2015(5):9284.
[9] 赵 枰,胡晓蓉,洪 宏,等.青少年非酒精性脂肪肝与血清脂联素水平及胰岛素抵抗的关系[J].现代检验医学杂志,2009,24(4):139-141. Zhao P,Hu XR,Hong H,et al.Relationship between serum adiponectinlevels and insulin resistance in adolescents with nonalcoholic fatty liver disease[J].Journal of Modern Laboratory Medicine,2009,24(4):139-141.
[10] Duwaerts CC,Maher JJ.Mechanis-ms of liver injury in non-alcoholic steatohepatitis[J].Curr Hepatol Rep,2014,13(2):119-129.
[11] Macaluso FS,Maida M,Petta S.Genetic background in nonalcoholic fattyliver disease:a comprehensive review[J].World Journal of Gastroenterology,2015,21(39):11088-11111.
[12] Ahmed M.Non-alcoholic fatty liver disease in 2015[J].World Journalof Hepatology,2015,7(11):1450-1459.
[13] Qu HQ,Li Q,Grove ML,et al.Population-based ri-sk factors for elevated alanine aminotransferase in a south texas Mexican-American population[J].Arch Med Res,2012,43(6):482-488.

相似文献/References:

[1]吴泽刚,李 艳,郑红云,等.恶性肿瘤患者UGT1A1基因启动子多态性检测结果分析[J].现代检验医学杂志,2015,30(03):35.[doi:10.3969/j.issn.1671-7414.2015.03.010]
　WU Ze-gang,LI Yan,ZHENG Hong-yun,et al.Analysis on Gene Polymorphism of UGT1A1 Gene Promoter in Patients with Malignant Tumour[J].Journal of Modern Laboratory Medicine,2015,30(04):35.[doi:10.3969/j.issn.1671-7414.2015.03.010]
[2]张艳梅,马靖华,刘阳晨,等.中国人群miR-449a单核苷酸多态性与胃癌易感性的相关性研究[J].现代检验医学杂志,2016,31(04):14.[doi:10.3969/j.issn.16717-414.2016.04.004]
　ZHANG Yan-mei,MA Jing-hua,LIU Yang-chen,et al.Correlation Study on miR-449a Gene Polymorphism of Single Nucleotide and Susceptibility to Gastric Cancer in A Chinese Han Population[J].Journal of Modern Laboratory Medicine,2016,31(04):14.[doi:10.3969/j.issn.16717-414.2016.04.004]
[3]陈 蕾,刘志忠,贾淑芬,等.双管单色荧光PCR法与基因芯片法检测CYP2C19基因多态性的比较研究[J].现代检验医学杂志,2016,31(04):51.[doi:10.3969/j.issn.16717-414.2016.04.013]
　CHEN Lei,LIU Zhi-zhong,JIA Shu-fen,et al.Comparing Study of Double Tube and One-Color Fluorescent PCR Technology and Gene Chip Method in Detecting the CYP2C19 Gene Polymorphisms[J].Journal of Modern Laboratory Medicine,2016,31(04):51.[doi:10.3969/j.issn.16717-414.2016.04.013]
[4]乔雪峰a,黄志平b,张 宁c,等.IL-18基因启动子区-137G/C,-607G/T 2个位点基因多态性与女性乳腺癌易感性Meta分析[J].现代检验医学杂志,2016,31(04):65.[doi:10.3969/j.issn.16717-414.2016.04.017]
　QIAO Xue-fenga,HUANG Zhi-pingb,ZHANG Ningc,et al.Association Analysis of IL-18 Gene Promoter Region -137G/C,-607G/T Polymorphisms and Susceptibility to Sporadic Breast Cancer:Meta-Analysis[J].Journal of Modern Laboratory Medicine,2016,31(04):65.[doi:10.3969/j.issn.16717-414.2016.04.017]
[5]孙 谦,周 辉,郭丽娜.血脂异常人群ApoE和SLCO1B1基因多态性及相关性研究[J].现代检验医学杂志,2017,32(06):28.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　SUN Qian,ZHOU Hui,GUO Li-na.Analysis of Dyslipidemia Correlation and Polymorphisms of ApoE and SLCO1B1 Gene in Dyslipidemia People[J].Journal of Modern Laboratory Medicine,2017,32(04):28.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[6]张阳东,周建荣,楚瑞雪,等.PECAM-1基因rs7503550位点多态性和表达水平与冠心病及2型糖尿病的相关性研究[J].现代检验医学杂志,2019,34(03):21.[doi:10.3969/j.issn.1671-7414.2019.03.005]
　ZHANG Yang-dong,ZHOU Jian-rong,CHU Rui-xue,et al.Relativity Study on rs7503550 Polymorphism and Genes Expression Levelsof PECAM-1 in Coronary Artery Disease and Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2019,34(04):21.[doi:10.3969/j.issn.1671-7414.2019.03.005]

备注/Memo

备注/Memo:

作者简介:宋 燕(1983-),女,硕士,主管技师,研究方向:肿瘤标志物和肿瘤免疫,Tel:010-59971406,E-mail:songyan07@126.com。
通讯作者:梁国威,男,主任医师,E-mail:lgw721@163.com。
更新日期/Last Update: 2016-08-10